Shapsis will determine the right medication and dosage based on your medical profile
In recent years, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as cornerstone therapies in the management of T2D and obesity [5,6,7]
Buteau from the University of Montreal in Quebec, Canada and colleagues, GLP-1 at physiological concentrations increased beta cell DNA synthesis that was independent of glucose
What can we help you with
The Kidney Disease: Improving Global Outcomes (KDIGO) organization provide a classification system for determining CKD risk based on cause , GFR , and albuminuria (Fig
Diabetic Retinopathy Complications in Patients with a History of Diabetic Retinopathy: Rapid improvement of glucose control has been associated with temporary worsening of diabetic retinopathy